Iverson L I, Ecker R R, Fox H E, May I A
Ann Thorac Surg. 1978 Mar;25(3):197-200. doi: 10.1016/s0003-4975(10)63521-7.
Following cardiac operations, 145 patients were treated with either intermittent positive-pressure breathing (IPPB), blod bottles, or an incentive spirometer in an attempt to alter the incidence of atelectasis. Pulmonary complications occurred in 30% of the patients receiving IPPB, 15% of those using an incentive spirometer, and 8% of those using blow bottles. Gastrointestinal side-effects occurred in 20% of the IPPB group and were rare in other groups. The cost of IPPB is also considerably greater than either incentive spirometry or blow bottles. IPPB is not essential to prevention of atelectasis in postoperative cardiac surgical patients and may be inferior to other methods.
在心脏手术后,145名患者接受了间歇正压通气(IPPB)、吹瓶或激励肺活量计治疗,以试图改变肺不张的发生率。接受IPPB治疗的患者中有30%发生肺部并发症,使用激励肺活量计的患者中有15%发生肺部并发症,使用吹瓶的患者中有8%发生肺部并发症。IPPB组有20%的患者出现胃肠道副作用,其他组则很少见。IPPB的成本也比激励肺活量计或吹瓶高得多。IPPB对于预防心脏手术后患者的肺不张并非必不可少,可能不如其他方法。